Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

AQSTAQST
Showing 8 of 12 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in AQUESTIVE THERAPEUTICS INC

WELLS FARGO & COMPANY/MN holds 1.1M shares of AQST (AQUESTIVE THERAPEUTICS INC), worth $4.5M as of 2026-Q2. The position was increased (+5.3% shares). AQST represents 0.0% of WELLS FARGO & COMPANY/MN's portfolio.

Current Value

$4.5M

Current Shares

1.1M

Total Value Change

+$4.4M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+5.3%
$4.5M0.0%$4.16
28
2026-Q1
Decreased
1M
-12.9%
$4.3M0.0%$4.12
0
2025-Q4
Increased
1.2M
+804.6%
$7.7M0.0%$6.38
44
2025-Q3
Increased
131,386
+27.0%
$734,4480.0%$5.65
31
2025-Q2
Increased
103,431
+86.5%
$342,3570.0%$3.25
37
2025-Q1
Increased
55,452
+7.6%
$160,8110.0%$3.02
17
2024-Q4
Increased
51,522
+54.3%
$183,4180.0%$3.52
22
2024-Q3
Increased
33,392
+3.3%
$166,2920.0%$4.72
16

Other major holders of AQST: BlackRock, Inc., RTW INVESTMENTS, LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used